The impact of adenomyosis on intrauterine insemination success in unexplained infertile women: a retrospective cross-sectional study
- PMID: 40462001
- PMCID: PMC12131557
- DOI: 10.1186/s12884-025-07769-9
The impact of adenomyosis on intrauterine insemination success in unexplained infertile women: a retrospective cross-sectional study
Abstract
Background: Adenomyosis is increasingly recognized as a significant factor affecting fertility, particularly in the context of assisted reproductive technologies (ART). This study aimed to assess the independent impact of adenomyosis on intrauterine insemination (IUI) success rates in women with unexplained infertility.
Methods: This retrospective cross-sectional study included 533 IUI cycles in 374 infertile women treated at the University of Health Science, assisted reproductive technologies center, Adana City Hospital. The study identified adenomyosis in 95 patients via 2D transvaginal Doppler ultrasonography and 3D transabdominal ultrasonography, whereas direct and indirect adenomyosis features were not detected in 279 patients. Both groups started ovulation induction on cycle day 2-3 using recombinant follicle stimulating hormone (rFSH) or letrozole combined with rFSH or rFSH combined with recombinant luteinizing hormone (rLH). Clinical and ultrasound findings were recorded systematically. IUI was performed 36 h post-human chorionic ggonadotropin (hCG) administration, with pregnancy defined as a positive β-hCG 12-14 days after IUI. Logistic regression models were used to analyze the independent effects of adenomyosis on clinical pregnancy rates, adjusting for potential confounders.
Results: The cumulative pregnancy rate per cycle was significantly lower in women with adenomyosis (12.23%) compared to those without adenomyosis (20.81%). Adenomyosis was identified as a significant negative predictor of IUI success (OR 0.575, 95% CI: 0.335-0.998, p = 0.049).
Conclusion: Adenomyosis negatively affects IUI outcomes, suggesting the need for tailored fertility treatment strategies in this population. Routine assessment of adenomyosis should be considered in infertility evaluations to optimize clinical management and treatment success.
Keywords: Adenomyosis; Intrauterine insemination; Ovulation induction; Reproductive outcomes; Transvaginal ultrasonography; Unexplained infertility.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval was granted through the Adana City Hospital Research Ethics Board (06.02.2025-365). The study obtained both verbal and written informed consent from all participating women. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.Hum Reprod. 2015 Jan;30(1):179-85. doi: 10.1093/humrep/deu302. Epub 2014 Nov 14. Hum Reprod. 2015. PMID: 25398971 Clinical Trial.
-
Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.J Obstet Gynaecol. 2021 Nov;41(8):1234-1239. doi: 10.1080/01443615.2020.1849069. Epub 2021 Feb 24. J Obstet Gynaecol. 2021. PMID: 33624571
-
Granulocyte colony stimulating factor (GCSF) did not affect the fertility outcomes in women with unexplained infertility after intrauterine insemination: a randomised clinical trial.J Obstet Gynaecol. 2022 Aug;42(6):2480-2485. doi: 10.1080/01443615.2022.2080534. Epub 2022 Jul 5. J Obstet Gynaecol. 2022. PMID: 35787135 Clinical Trial.
-
Intra-uterine insemination for unexplained subfertility.Cochrane Database Syst Rev. 2020 Mar 3;3(3):CD001838. doi: 10.1002/14651858.CD001838.pub6. Cochrane Database Syst Rev. 2020. PMID: 32124980 Free PMC article.
-
Ovarian stimulation strategies for intrauterine insemination in couples with unexplained infertility: a systematic review and individual participant data meta-analysis.Hum Reprod Update. 2022 Aug 25;28(5):733-746. doi: 10.1093/humupd/dmac021. Hum Reprod Update. 2022. PMID: 35587030 Free PMC article.
References
-
- Osmanlioglu S, Sukur YE, Tokgoz VY, Ozmen B, Sonmezer M, Berker B, Aytac R, Atabekoglu CS. Intrauterine insemination with ovarian stimulation is a successful step prior to assisted reproductive technology for couples with unexplained infertility. J Obstet Gynaecol. 2022;42:472–7. - PubMed
-
- Vichinsartvichai P, Siriphadung S, Traipak K, Promrungrueng P, Manolertthewan C, Ratchanon S. The influence of women age and successfulness of intrauterine insemination (IUI) cycles. J Med Assoc Thai. 2015;98:833–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical